IceCure Reports Positive Results In Tumor-Freezing Breast Cancer Trial
IceCure's ProSense is a liquid-nitrogen-based cryoablation system used in the treatment of patients with T1 invasive breast cancer.
May 09, 2021
IceCure’s Tumor-Freezing System Nabs FDA Breakthrough Device Status
IceCure's ProSense cryoablation system is used to treat patients with T1 invasive breast cancer or those not suited for surgical alternatives.
April 06, 2021
IceCure Expands Deal With Japanese Medical Device Firm Terumo
The new agreement will grant Terumo exclusive rights to distribute IceCure products in Thailand over the course of six years.
October 04, 2020
Israeli Firm Freezing Cancer Tumors Raises $6M In Equity Offering
IceCure Medical's cryoablation technology treats benign and malignant tumors by freezing them and turning them into ice balls.
August 09, 2020
Israeli Firm That Freezes Cancer Tumors Signs Distribution Deal In Japan, Singapore
IceCure Medical developed cryoablation systems for treating malignant and benign tumors.
September 02, 2019
Best Of 2018: 15 ‘Superhero’ Israeli Startups Changing The World
From humanitarian assistance and plastic reduction to water sanitation and space missions, NoCamels presents a selection of remarkable companies that had a positive impact this past year.
December 27, 2018
Israeli Firm That Freezes Cancer Tumors To Launch Treatments At Haifa Hospital
IceCure Medical says it will start providing treatments for eliminating cancerous kidney tumors and benign breast tumors at Elisha Hospital in northern Israel next month.
August 15, 2018
Israeli Startup Freezing Cancer In Its Tracks Now Tackling Kidney, Liver, Bone Tumors
IceCure Medical has developed technology to treat benign and malignant cancer tumors, turning them into ice balls
March 12, 2018
